Physician profile
Lance Delong
NPI 1205165974
$1,418.66
in general payments reported to CMS, 2019-2025
11 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $385 · 2022: $478 · 2024: $300 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $807.78 | 2021-2025 | |
| Lilly USA, LLC | $160.68 | 2021-2022 | |
| Mylan Specialty L.P. | $111.82 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $89.26 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $84.37 | 2021-2024 | Airsupra, Breztri |
| Novo Nordisk INC | $70.93 | 2021-2022 | |
| Glaxosmithkline, LLC. | $25.16 | 2021 | |
| Merck Sharp & Dohme LLC | $22.70 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.04 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.07 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Delong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.